• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.

作者信息

Evans Douglas B, Hess Kenneth R, Pisters Peter W T

出版信息

Ann Surg. 2002 Nov;236(5):694; author reply 694-6. doi: 10.1097/01.SLA.0000037256.09376.FC.

DOI:10.1097/01.SLA.0000037256.09376.FC
PMID:12409677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1422632/
Abstract
摘要

相似文献

1
ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.ESPAC-1可切除胰腺癌辅助治疗试验
Ann Surg. 2002 Nov;236(5):694; author reply 694-6. doi: 10.1097/01.SLA.0000037256.09376.FC.
2
[Long term survival after pancreatic resection for pancreatic adenocarcinoma].[胰腺癌切除术后的长期生存]
Z Gastroenterol. 2002 Sep;40(9):849-52. doi: 10.1055/s-2002-33871.
3
Adjuvant treatment for resectable pancreatic cancer.可切除胰腺癌的辅助治疗。
J Clin Oncol. 2005 Jul 10;23(20):4532-7. doi: 10.1200/JCO.2005.17.954.
4
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.胰腺癌辅助治疗中的放射疗法。
Semin Oncol. 2005 Dec;32(6 Suppl 9):S30-2. doi: 10.1053/j.seminoncol.2005.04.015.
5
[Current aspects of diagnosis and therapy of pancreatic carcinoma].[胰腺癌诊断与治疗的当前进展]
Z Gastroenterol. 2002 Dec;40 Suppl 2:62-3. doi: 10.1055/s-2002-35889.
6
The case for routine use of adjuvant therapy in pancreatic cancer.胰腺癌辅助治疗常规使用的理由。
J Surg Oncol. 2007 Jun 1;95(7):597-603. doi: 10.1002/jso.20719.
7
An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.可切除性胰腺腺癌手术管理的循证方法
J Am Coll Surg. 2003 Jun;196(6):954-64. doi: 10.1016/S1072-7515(03)00010-3.
8
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存：能否治愈？
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.
9
[Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports].[腺癌的胰腺切除术：预后因素、病理报告建议]
Ann Pathol. 2002 Oct;22(5):422-31.
10
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.对于交界性胰腺腺癌，在切除术前先进行放化疗，然后再进行化疗。
Am J Surg. 2008 Mar;195(3):318-21. doi: 10.1016/j.amjsurg.2007.12.017.

引用本文的文献

1
Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer.新辅助放化疗后增强的抗肿瘤免疫介导了可切除胰腺癌女性患者的良好预后。
Gut. 2024 Jan 5;73(2):311-324. doi: 10.1136/gutjnl-2023-330480.
2
Survival outcomes of surgical and non-surgical treatment in elderly patients with stage I pancreatic cancer: A population-based analysis.老年I期胰腺癌患者手术与非手术治疗的生存结局：一项基于人群的分析。
Front Med (Lausanne). 2022 Sep 29;9:958257. doi: 10.3389/fmed.2022.958257. eCollection 2022.
3
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.放射治疗诱导 ADAM10 驱动胰腺癌纤维化、耐药和上皮间质转化。
Cancer Res. 2021 Jun 15;81(12):3255-3269. doi: 10.1158/0008-5472.CAN-20-3892. Epub 2021 Feb 1.
4
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.胰腺癌的辅助放化疗：放疗剂量对生存的影响。
BMC Cancer. 2019 Jun 11;19(1):569. doi: 10.1186/s12885-019-5790-2.
5
Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins.辅助性胰腺立体定向体部放射治疗切缘接近或阳性的前瞻性研究的初步结果
Adv Radiat Oncol. 2018 Nov 29;4(2):294-301. doi: 10.1016/j.adro.2018.11.007. eCollection 2019 Apr-Jun.
6
Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail.辅助放疗对切除的胰尾腺癌具有生存获益。
J Gastrointest Oncol. 2018 Jun;9(3):487-494. doi: 10.21037/jgo.2018.02.02.
7
A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care.双城记：重新审视胰腺癌治疗中的辅助放疗
J Gastrointest Surg. 2016 Jan;20(1):85-92; discussion 92. doi: 10.1007/s11605-015-2951-8. Epub 2015 Oct 1.
8
Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.辅助放疗或单纯吉西他滨化疗后淋巴结阳性的切除胰腺癌的失败模式
J Gastrointest Cancer. 2015 Jun;46(2):149-55. doi: 10.1007/s12029-015-9702-7.
9
Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma.胰腺腺癌的辅助和新辅助全身治疗。
Semin Oncol. 2015 Feb;42(1):134-43. doi: 10.1053/j.seminoncol.2014.12.012. Epub 2014 Dec 9.
10
Current status of adjuvant therapy for pancreatic cancer.胰腺癌辅助治疗的现状。
Oncologist. 2010;15(11):1205-13. doi: 10.1634/theoncologist.2010-0121. Epub 2010 Nov 2.

本文引用的文献

1
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.在ESPAC-1随机对照试验中，手术切缘对接受辅助放化疗和/或化疗的胰腺癌患者生存的影响。
Ann Surg. 2001 Dec;234(6):758-68. doi: 10.1097/00000658-200112000-00007.
2
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.可切除胰腺癌的辅助放化疗与化疗：一项随机对照试验
Lancet. 2001 Nov 10;358(9293):1576-85. doi: 10.1016/s0140-6736(01)06651-x.